Financial De-Escalation in T1 Breast Cancers With the Low Magee Equation: An Experience From A Single Institution Without Genomic Testing
{{output}}
Objective: The Oncotype Dx® assay is a validated tool for determining prognosis and predicting benefit from adjuvant systemic chemotherapy in patients with node-negative, early-stage hormone receptor (HR)-positive, human epiderm... ...
